Form 4 holding
Director
Inhibrx Biosciences, Inc.
- Security class
- Common Stock
- Shares / value
- 429,360
- Estimated value
- $42,936,000
- Report date
- 16 Sep 2026
- Price
- $100.00
- Ownership
- By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust